SCHEMBL14545972

SCHEMBL14545972

Cc1cnn2c(NCCNC(=O)c3ccc(O)cc3)cc(-c3ccccc3Cl)nc12

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 4/20 0.46
▸ CDK2 P24941 4/20 0.46
▸ ALDH1A1 P00352 3/20 0.40
▸ MAPT P10636 2/20 0.40
▸ MAPK1 P28482 2/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ PDE2A O00408 5/20 0.39
▸ PDE10A Q9Y233 4/20 0.39
▸ MEN1 O00255 2/20 0.38
▸ KMT2A Q03164 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ DEGS1 O15121 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13288943 0.85 BRD4 (0.44) GSK3BCDK2ALDH1A1MAPTMAPK1
SCHEMBL14418845 0.84 ALDH1A1 (0.43) GSK3BCDK2ALDH1A1MAPTMAPK1
SCHEMBL13120284 0.83 CDK2 (0.60) GSK3BCDK2KMT2A
SCHEMBL13304619 0.82 GSK3B (0.55) GSK3BCDK2ALDH1A1MAPTMAPK1
SCHEMBL13120304 0.81 CDK2 (0.58) GSK3BCDK2
SCHEMBL13288754 0.81 CDK2 (0.45) GSK3BCDK2MAPTMEN1KMT2A
SCHEMBL13120278 0.81 GSK3B (0.57) GSK3BCDK2MAPTMEN1KMT2A
SCHEMBL13120285 0.81 GSK3B (0.57) GSK3BCDK2
SCHEMBL13288895 0.81 GSK3B (0.43) GSK3BCDK2ALDH1A1MAPTMAPK1
SCHEMBL14043329 0.80 KISS1R (0.38) GSK3BCDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007044449-A2 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2007-04-19 — — WO disclosed
Send feedback